In the present study, we not only explored the mechanism of TMTC3 in modulating angiogenesis of ESCC in the hypoxic TME, but also provided an efficient therapeutic strategy against TMTC3 high expression tumors. The gene discussed is TMTC3; the disease is esophageal squamous cell carcinoma.